Jacob D. Soumerai, MD, Aliyah R. Sohani, MD, and Jeremy S. Abramson, MD

All articles by Jacob D. Soumerai, MD, Aliyah R. Sohani, MD, and Jeremy S. Abramson, MD

Diagnosis and Management of Castleman Disease

November 26, 2014

[Cancer Control] Castleman disease is a lesser seen lymphoproliferative disorder, which is characterized as either localized or multicentric, with differing treatments typically utilized for each type.

Next post in Hematologic Cancers

Jacob D. Soumerai, MD, Aliyah R. Sohani, MD, and Jeremy S. Abramson, MD

All articles by Jacob D. Soumerai, MD, Aliyah R. Sohani, MD, and Jeremy S. Abramson, MD

Diagnosis and Management of Castleman Disease

Panobinostat Is Not Ready for U.S. Market According to the Oncologic Drugs Advisory Committee